A Phase 4, Open-label, Multicentre, 2-Year Safety Study of Lisdexamfetamine Dimesylate in Children and Adolescents Aged 6-17 Years with Attention-Deficit/Hyperactivity Disorder (ADHD)
Laufzeit: 01.01.2011 - 31.12.2014
imported
Kurzfassung
Phase 4 Open-label, 2-jährige Safety Studie
Beteiligte Einrichtungen
